Medtronic has secured a CE mark approval in Europe for its surgical implant to close the heart’s left atrial appendage, aimed at reducing the long-term risk of stroke that’s higher…
Nearly three years after miniature heart pump maker Abiomed completed its sale to Johnson & Johnson, its former CEO is looking to trade the board room for the state house.…
Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The BioInsight division plans…
The FDA is amplifying a recall effort underway at Siemens Healthineers related to several of its MRI machines, linked to their helium containment and the potential for a dangerous rupture.…
After pivoting at the top of this year from treating diabetes to focusing on an obesity landscape dominated by GLP-1s, Fractyl Health has shown that its one-time procedure can help…
Olympus is launching what it describes as its first in a series of artificial intelligence-powered applications bound for the U.S., starting with a program designed to assist in detecting polyps…
Marking Siemens Healthineers’ second robotics partnership this month, the company has signed on to help sell Interventional Systems’ miniature device designed for image-guided and needle-based procedures. Interventional Systems’ Micromate is…
After raising $100 million in venture capital funding earlier this year, Biolinq has obtained a groundbreaking green light from the FDA for its needle-free continuous glucose monitor. The Shine system,…
The FDA has handed a groundbreaking clearance to EssilorLuxottica and its eyeglasses to help slow the progression of nearsightedness in young children—a rapidly increasing condition among U.S. adolescents and one…
The U.S. government has launched a wide-ranging probe into the medtech industry and its international supply chain as a step before potentially imposing new and higher tariffs on devicemakers. Known…